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ABSTRACT 
The aim of this study was to use Spectral Domain-Optical Coherence Tomography (SD-OCT) to measure the thickness of 
the Macular Inner Retinal Layer (MIRL) and compare the results between diabetic patients with no signs of retinopathy 
and healthy subjects. 
Overall, 47 type 2 diabetic patients without clinical signs of retinopathy were prospectively analyzed along with 36 
healthy subjects. This study excluded patients with other systemic or ocular diseases. All patients had their MIRL 
thickness measured by RTVue-100 SD-OCT (7x7 mm macular grid). The MIRL thickness is provided by the ganglion cell 
complex scan (comprised of the retinal nerve fiber, ganglion cell, and inner plexiform layers). Only one eye was randomly 
selected if both were eligible for analysis. 
Mean age was similar between the two groups (diabetic patients: 57.3 ± 10.6 and control subjects: 60.2 ± 12.2 years) (P = 
0.19). No significant differences regarding optic disc area and cup-to-disc ratio was observed in the comparison of the 
two groups (P ≥ 0.38 for both comparisons). In patients with diabetes, the average MIRL was significantly thinner when 
compared to controls (91.6 versus 96.2 micrometer (µm); P = 0.02). Regional analysis revealed superior and inferior MIRL 
to be significantly thinner in patients with diabetes than the controls (P ≤ 0.04). The juxtafoveal area was compromised 
(thinned) in 70% of diabetic eyes, classified as abnormal (P < 1%; compared to the device’s normative database). 
In conclusion, patients with type 2 diabetes without clinical evidence of retinopathy had lower MIRL average values 
when compared to the control group. This can be explained by the ischemia and retinal tissue injury caused by diabetes 
even in early stages of diabetic retinopathy, which can affect MIRL thickness. Possible implications of these findings on 
diagnosis and treatment of diabetic retinopathy requires further investigation. 
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INTRODUCTION
Diabetic Retinopathy (DR) is one of the most important 
causes of blindness, worldwide [1, 2]. It is characterized 
by alterations of the retinal microvasculature and 
involves endothelial cells and pericytes loss [1, 2]. 
Resulting features include microaneurysms, 
hemorrhages, capillary non-perfusion, and 
neovascularization [1, 2]. There is evidence suggesting 
that functional impairment usually precedes the earliest 
clinical manifestations of diabetic retinal vasculopathy. 
Focal Retinal Nerve Fiber Layer (RNFL) loss in diabetic 
patients with preclinical DR, detected by red-free fundus 
photograph, was first described by Chihara et al. [3]. 
Later, Lopes de Faria et al. found localized RNFL loss in 
patients with type 1 diabetes (T1DM) without signs of 
retinopathy, by scanning laser polarimetry [4]. Recently, 
Kim et al. found that patients with DR progression 
exhibited, among other systemic changes, longer Type 2 
Diabetes Mellitus (T2DM) duration, thinner macular 
Ganglion Cell-Inner Plexiform Layer (mGCIPL), and 
greater mGCIPL thinning rate [5]. Also, in vitro studies 
have demonstrated that diabetes influences both retinal 
neurons and glial cells; Retinal Ganglion Cells (RGCs) 
apoptosis was observed even before the onset of 
retinopathy [6, 7]. 
Optical Coherence Tomography (OCT) is a tool that 
allows quantitative measurements of retinal thickness 
[8-10]. It provides cross-sectional images of the retina 
and useful information on vitreoretinal changes 
associated with a high diversity of ocular diseases [8-
10]. Spectral-Domain OCT (SD-OCT) is one of the latest 
generations of techniques and provides images with 
high axial resolution and quality [11-13]. In addition, it 
allows identification of individual retinal layers 
approaching histological detail with significant 
information in several diseases [14-17]. The Ganglion 
Cell Complex (GCC) scan was designed to improve 
glaucoma diagnosis and is composed of the inner 
three layers of the retina (RNFL; ganglion cell layer and 
inner plexiform layer) [16, 18, 19]. 
Although retinopathy is a long-known complication of 
diabetes, the relationship between RNFL thickness and 
diabetes in the early stage of the disease has only 
recently been established. Tekin et al. compared children 
with Type 1 DM (T1DM) without retinopathy with a 
control group, and suggested that retinal neural changes, 
shown by SD-OCT, could be present in diabetic eyes, 
even before clinically detectable retinal vasculopathy 
[20]. On the other hand, Pekel et al. did not find any 
differences in the RNFL thickness of children with T1DM, 
yet found that binocular RNFL thickness symmetry 
percentage was significantly different in diabetic and 
control groups [21]. Other groups also corroborated that 
neurodegeneration by T2DM may play a role in the 
thinning of GCC, using the SD-OCT [20, 22-28]. 
Considering the mentioned points, the current authors 
hypothesized that even in the early stage of the disease, 
diabetes leads to ischemia and retinal tissue injury, 
affecting Macular Inner Retinal Layer (MIRL) thickness. 
Therefore, this study aimed at comparing values of MIRL 
thickness obtained by a SD-OCT device between diabetic 
patients without clinical signs of retinopathy and healthy 
subjects. 
MATERIALS and METHODS 
A prospective study was carried out. The protocol 
adhered to the tenets of the Declaration of Helsinki and 
was approved by the Institutional Review Board. In 
addition, written informed consent was obtained from all 
subjects. 
Patients 
Diabetic patients without clinical signs of retinopathy and 
healthy subjects were consecutively enrolled in this 
study. Patients with minimal visible changes of diabetic 
retinopathy (such as microaneurysms, macular edema, 
macular, macular thickening, or any sign of diabetic 
retinopathy), other ocular diseases, media opacities 
(excluding mild cataract), history of ocular trauma or 
surgery, refractive error greater than ± 5 Diopter (D), 
spherical or cylindrical corneal thickness greater than ± 
3D, and central corneal thickness (based on ultrasound 
pachymetry) above 600 micrometer (µm) or below 450 
µm were excluded. Eyes with glaucoma were excluded 
based on IOP ≥ 21 mmHg and clinical signs of neuropathy 
or visual field suggestive findings. Baseline data included 
age, gender, race, presence of T2DM, and time of 
diagnosis (based on the information provided by 
patients). Two masked ophthalmologists classified the 
patients and when there was any disagreement, a third 
ophthalmologist was recruited. Therefore, when no 
criteria for DR was found, the patient was classified as 
“no retinopathy” and if any criteria for DR (based on 
ETDRS) was found in the clinical examination, these 
patients were excluded [26-28]. 
Diabetes was defined according to self-reported 
physician diagnosis, and all patients with diabetes were 
under medical treatment within at least six months 
(using only oral hypoglycemic agents). Healthy subjects 
were recruited from the general population or from 
spouses and relatives of patients with diabetes. They 
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were defined as having self-reported history of normal 
glucose level in the past two years. 
Procedures 
All participants underwent a complete ophthalmic 
evaluation, including slit lamp biomicroscopic 
examination, Goldman applanation tonometry, and 
fundoscopy with pupil dilation. Fundus photography was 
performed for all patients. Grading of DR and presence of 
diabetic macular edema were based on the International 
Clinical Diabetic Retinopathy Disease Severity Scale [29].
 
Analysis of MIRL thickness was performed using SD-OCT 
(GCC scan; RTVue-100 OCT; Optovue, Inc., Fremont, CA). 
The GCC scan consisted of 15 vertical line scans covering 
a seven-square millimeter (mm²) region. It was centered 
at 1-mm temporal to the fovea center for better 
coverage of the temporal region. The GCC scan also 
included a horizontal line scan at the middle for 
registration of vertical scans and fovea center searching. 
In total, it captured 15.000 data points within 0.6 
seconds. The OCT scans are processed automatically to 
provide a thickness map of the GCC, which is defined by 
the distance from the internal limiting membrane to 
outer inner plexiform layer and is composed of the inner 
three layers of the retina. Some parameters of the optic 
nerve head report were used for analysis and included 
the optic disc area and cup-to-disc ratio. For this study, 
images with signal strength index less than 40 or those 
that were not well-centered (subjective assessment) 
were excluded from the analysis [30]. 
Statistical Analysis 
Descriptive statistics included mean and standard 
deviation (SD) values for normally distributed variables. 
This study used Skewness/Kurtosis tests and histograms 
to check for normality. Independent samples T-test was 
used to compare different SD-OCT parameters between 
groups and other continuous variables. Categorical data 
were compared using the chi-square test. Whenever 
both eyes were eligible, one was randomly selected for 
analysis. All statistical analyses were performed with a 
commercially available software, Medcalc version 7.4.2.0 
(Medcalc Software, Mariakerke, Belgium). The α level 
(type I error) was set at 0.05. 
RESULTS 
A total of 36 healthy subjects (36 eyes) and 47 patients 
with diabetes (47 eyes) were enrolled. Table 1 shows 
baseline characteristics of the groups, including age, 
gender, race, and mean values of disc size and vertical 
cup-to-disc ratio. Mean ± SD of age was similar between 
patients with diabetes and control subjects (57.3 ± 10.6 
and 60.2 ± 12.2 years, respectively; P = 0.19). There were 
no significant differences regarding optic disc area (P = 




Table 1: Demographic characteristics of the studied subjects 
Variables Control Group (n = 27) Diabetic Group (n = 38) P value 
Age (years) (Mean ± SD) 60.3 ± 12.4 56.3 ± 10.8 0.18 
Gender (F/M) (n) 12/15 25/13 0.14 
Race (C/O) (n) 16/11 27/11 0.46 
Optic Disc Size (mm
2
) (Mean ± SD) 1.94 ± 0.47 2.02 ± 0.6 0.59 
C/D Ratio (Mean ± SD) 0.38 ± 0.16 0.34 ± 0.17 0.38 
F: female; M: male; C: Caucasian; O: others; C/D: cup-to-disc; n: number; SD: standard deviation 
Data in table are presented as mean ± SD. 
 
 
Figure 1: Ganglion Cell Complex (GCC) Analysis Results from Three Different Patients with Diabetes Included in the Current Study. 
These Three Cases represent Three Different Patterns of GCC Thinning. (A) Perifoveal Thinning; (B) Peripheral Thinning; and (C) Diffuse Thinning. 
OD, Right Eye; T, Temporal; N, Nasal. 
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Average MIRL was significantly thinner in patients with 
diabetes compared to controls (91.6 versus 96.2 µm; P = 
0.02). Additionally, regional analysis revealed superior 
(91.5 vs 96.3 µm; P = 0.02) and inferior mean values (91.7 
versus 96.1 µm; P = 0.04) to be significantly thinner in 
patients with diabetes compared with controls. Although 
a greater difference between groups was found in the 
superior macular region (-4.8 µm) when compared to the 
inferior macular region (-4.4 µm), this difference was not 
statistically significant (P = 0.35). 
Finally, 70% of all diabetic eyes, analyzed in this study, 
had an abnormal area on GCC significance map (reduced 
thickness; P < 1%), as classified by the device´s normative 
database. In 70% of eyes, the juxtafoveal area was the 
affected (thinned) one. Three cases representing 
different patterns of GCC thinning are provided in Figure 
1. 
DISCUSSION 
This research found that patients with T2DM without 
clinical evidence of DR have lower MIRL average values 
when compared to the control group. This difference 
appears to be more pronounced in the superior macula 
(although it was not statistically different), and the 
juxtafoveal area was more affected in most patients. 
Glaucoma is an optic neuropathy, characterized by loss of 
RGCs and their respective axons. In this context, GCC 
analysis was specifically designed to improve glaucoma 
diagnosis accuracy [31].
 
It has been shown that its 
diagnostic power is higher than total macular thickness. 
Additionally, the combination of faster speed (high-
density scanning over a large region of the macula with 
less motion artifact) and higher resolution images with 
the SD-OCT significantly improved the precision of GCC 
measurements, which could improve the ability to track 
glaucomatous thinning over time [18]. 
Several studies of histological material have 
demonstrated that RGCs seem to be lost in diabetic 
patients [6, 32]. Immunohistochemical studies have 
shown that RGCs undergo apoptosis in humans with 
diabetes, leading to a reduction in the thickness of 
RNFL [6, 32]. Moreover, in vivo use of scanning laser 
polarimetry and other techniques, such as OCT, found 
significant thinning of the RNFL in diabetic eyes (likely 
to be due to loss of RGCs and their axons in this 
disease), even without clinical signs of retinopathy [3, 
4, 33].
 
Functional changes, such as deficits in the 
electro-retinogram and reduced contrast sensitivity 
can occur before the gross vascular defects become 
clinically detectable [34, 35]. Some studies have 
investigated early changes of DR in the inner retina 
(ganglion cell layer) using OCT, and the results are 
consistent with the current findings
 
[20, 22, 28]. 
Patients with no or minimal DR changes underwent 
OCT examination with automated segmentation of 
intra-retinal layers, using a custom-built algorithm
 
[26]. The authors found reduced values for RNFL 
thickness and ganglion cell/inner plexiform layer 
complex thickness only in the group with mild DR
 
[26]. 
In the present study, patients with no retinal 
abnormalities were included and they were found to 
have significantly reduced MIRL thickness when 
compared to controls. Using SD-OCT, a recent study 
found that superior macular GCC thicknesses were 
significantly decreased in diabetic cases without 
retinopathy, and no significant peripapillary RNFL 
thickness changes were observed [27]. These results 
are in accordance with the current findings, and prove 
that GCC reduction occurs much earlier than 
peripapillary RNFL thinning in diabetic patients 
without retinopathy [27]. 
Using a different imaging technology (scanning laser 
polarimetry), Lopes de Faria et al. [4] also found a 
significant nerve fiber layer loss in the superior segment 
of the retina in patients with T1DM mellitus without 
retinopathy. Although only patients with T2DM were 
included in the current study, a more pronounced 
thinning of the MIRL in the superior hemisphere was also 
found (even though this difference did not reach 
statistical significance). If there is an asymmetric 
structural loss, it is still to be determined and better 
understood. Another recent study used a multivariable 
analysis to compare The Ganglion Cell Inner Plexiform 
Layer (GCIPL), using the SD-OCT, between controls and 
T2DM with and without RNFL defects [28]. This study 
showed that diabetic eyes with RNFL defects had a 
significantly thinner average GCIPL thickness than those 
without RNFL defects. Also, the presence of early and 
definite Cardiovascular Autonomic Neuropathy (CAN) 
contributed significantly more to the decreased average 
GCIPL thickness, relative to the absence of CAN 
involvement. These results may be used, in the future, as 
markers of early neurodegenerative changes during 
diabetes [28]. 
The findings of this study corroborate with the main 
hypothesis that diabetic retinal neuropathy is caused by 
direct damage from chronic hyperglycemia, and is not 
the effect of vascular DR. However, the exact nature of 
their interdependence is not yet known. Each process, 
once established, probably contributes to the 
progression of the other. The hypothesis that diabetes 
 
 
Med Hypothesis Discov Innov Ophthalmol. 2018; 7(3)  
 
137 MACULAR INNER RETINAL LAYER THINNING IN DIABETIC PATIENTS 
may cause retinal neuropathy independent of 
retinopathy is peculiar and curious, and potentially links 
retinal neuropathy to other diabetic neuropathies [27, 
36]. Neuro-retinal degeneration creates several 
metabolic and signaling pathways, which are involved in 
the microangiopathic process as well as in the 
disruption of the blood-retinal barrier, which is a crucial 
element in the pathogenesis of DR [27, 37]. 
It is important to mention some specific characteristics of 
the current study. Since this study was cross-sectional, 
the researchers could not evaluate the possible effects of 
retinopathy progression on MIRL thickness 
measurements. This may help better understanding of 
the effects of diabetes on the inner retinal layers. 
Moreover, the time of T2DM diagnosis was based on the 
information provided by patients, which is subjective and 
probably lacks reliability. Finally, glycemic control, which 
was not evaluated in the current study, might be 
correlated to MIRL changes and should be addressed by 
further studies. Furthermore, another relevant analysis 
that could be addressed by future studies is the 
evaluation of fluorescein angiography or Optical 
Coherence Tomography Angiography (OCTA) in diabetic 
patients without clinical retinopathy, which could be 
relevant to understand the relationship with MIRL 
thickness, obtained by a SD-OCT. 
CONCLUSIONS 
In conclusion, T2DM patients without retinopathy have 
reduced average MIRL values when compared to normal 
subjects, even though the vascular component of DR is 
absent. This difference seems to be more pronounced 
juxtafoveally, and it could be a marker of early 
manifestations in diabetic patients [28]. Possible 
implications of these findings on diagnosis and treatment 
of DR require further investigation. 
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